Clinical Trials on CAR - T CD19/CD20/CD22/CD30 in Korea, Republic of

Total 2 results

Seoul National University Hospital
Gyeongsang National University Hospital; Hallym University Medical Center; Kyunghee...

Terminated

Rituximab Plus MG4101 Indolent CD20-positive Non-Hodgkin Lymphoma (NHL) (MG4101)

CD20-positive Non-Hodgkin Lymphoma

Korea, Republic of
Seoul National University Hospital

Recruiting

Treatment of CD19 Chimeric Antigen Receptor T Cells for Pediatric Patients With CD19-positive B-cell Acute Lymphoblastic Leukemia Who Are Indicated for Hematopoietic Stem Cell Transplantation

Very High Risk Acute Lymphoblastic Leukemia | CD19 CAR-T Therapy

Korea, Republic of

3

Subscribe